Text Size

Hybrid Transvaginal-Transabdominal Endoscopic Surgery

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2011 by St. Luke's-Roosevelt Hospital Center.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
St. Luke's-Roosevelt Hospital Center
ClinicalTrials.gov Identifier:
NCT01039129
First received: December 22, 2009
Last updated: February 22, 2011
Last verified: February 2011
History of Changes
  Purpose

The is a pilot study to evaluate the safety and efficacy of hybrid transvaginal-transabdominal procedures. Diagnostic peritoneoscopy (visualizing the inside of the abdomen), appendectomy (removal of the appendix), and cholecystectomy (removal of the gallbladder) will be performed through a vaginal incision with an additional small incision in the umbilicus.


Condition Intervention
Gallstones
Appendicitis
Pelvic Pain
Peritoneal Mass
 Procedure: Hybrid Transvaginal-Transabdominal Endoscopic Surgery

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Hybrid Transvaginal-Transabdominal Endoscopic Surgery

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by St. Luke's-Roosevelt Hospital Center:

Primary Outcome Measures:
  • Technical success [ Time Frame: intra-operative ] [ Designated as safety issue: No ]
  • Complication [ Time Frame: 1 month ] [ Designated as safety issue: Yes ]

Secondary Outcome Measures:
  • Operative time [ Time Frame: intra-operative ] [ Designated as safety issue: No ]
  • Sexual function [ Time Frame: 1 year ] [ Designated as safety issue: No ]

Estimated Enrollment: 60
Study Start Date: December 2009
Estimated Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Hybrid Transvaginal-Transabdominal Endoscopic Cholecystectomy
20 patients in this arm will undergo cholecystectomy, or removal of the gallbladder, through this experimental approach. This arm will compose of patients with symptomatic gallstones (cholelithiasis).
 Procedure: Hybrid Transvaginal-Transabdominal Endoscopic Surgery
An incision will be made in the vagina and a flexible surgical camera (endoscope) and instruments will be introduced. The surgical procedure for each given arm will be performed with the aid of an additional surgical instrument inserted through a small incision in the umbilicus.
Experimental: Hybrid Transvaginal-Transabdominal Endoscopic Appendectomy
20 patients in this arm will undergo appendectomy, or removal of the appendix, through this experimental approach. This arm will be composed of patients with chronic appendicitis that has abated or early acute appendicitis.
 Procedure: Hybrid Transvaginal-Transabdominal Endoscopic Surgery
An incision will be made in the vagina and a flexible surgical camera (endoscope) and instruments will be introduced. The surgical procedure for each given arm will be performed with the aid of an additional surgical instrument inserted through a small incision in the umbilicus.
Experimental: Hybrid Transvaginal-Transabdominal Endoscopic Peritoneoscopy
20 patients in this arm will undergo diagnostic peritoneoscopy with or without biopsy for any indication.
 Procedure: Hybrid Transvaginal-Transabdominal Endoscopic Surgery
An incision will be made in the vagina and a flexible surgical camera (endoscope) and instruments will be introduced. The surgical procedure for each given arm will be performed with the aid of an additional surgical instrument inserted through a small incision in the umbilicus.

  Eligibility

Ages Eligible for Study:   18 Years to 60 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Chronic or early appendicitis
  • Symptomatic gallstones
  • Suspicious abdominal mass/nodule
  • Female
  • Age 18-60 years
  • ASA Class I or II

Exclusion Criteria:

  • Pregnant women
  • History of previous abdominal, pelvic, or vaginal surgery
  • History of previous abdominal or pelvic radiation therapy
  • History of fibroid uterus
  • History of endometriosis
  • History of large ovarian cyst
  • History of unexplained vaginal bleeding or dyspareunia
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01039129

Contacts
Contact: Julio Teixeira, MD 212-523-2184 jteixeira@chpnet.org

Locations
United States, New York
St. Luke's-Roosevelt Hospital Center Recruiting
New York, New York, United States, 10025
Contact: Julio Teixeira, MD     212-523-2184     jteixeira@chpnet.org    
Sponsors and Collaborators
St. Luke's-Roosevelt Hospital Center
Investigators
Principal Investigator: Julio Teixeira, MD St. Luke's-Roosevelt Hospital Center, Department of Surgery
  More Information

No publications provided

Responsible Party: Julio Teixeira, MD, St. Luke's-Roosevelt Hospital Center, Department of Surgery
ClinicalTrials.gov Identifier: NCT01039129     History of Changes
Other Study ID Numbers: SLR IRB#09-136
Study First Received: December 22, 2009
Last Updated: February 22, 2011
Health Authority: United States: Institutional Review Board

Keywords provided by St. Luke's-Roosevelt Hospital Center:
Gallstones
Appendicitis
Pelvic pain
Peritoneal mass

Additional relevant MeSH terms:
Appendicitis
Acute Disease
Gallstones
Cholelithiasis
Cholecystolithiasis
Pelvic Pain
Gastroenteritis
Gastrointestinal Diseases
Digestive System Diseases
Cecal Diseases
 Intestinal Diseases
Disease Attributes
Pathologic Processes
Biliary Tract Diseases
Gallbladder Diseases
Calculi
Pathological Conditions, Anatomical
Pain
Signs and Symptoms

ClinicalTrials.gov processed this record on May 21, 2013